Daisuke Aoki - Gynecology

Author Information

Daisuke Aoki is a distinguished researcher affiliated with the Department of Obstetrics and Gynecology at Keio University School of Medicine in Tokyo, Japan. His work primarily focuses on gynecologic oncology, fertility preservation, and advanced surgical techniques in gynecology. Aoki's contributions have significantly advanced the understanding and treatment of various gynecologic malignancies.

Research Contributions

Daisuke Aoki has authored numerous influential papers, particularly in the fields of ovarian cancer, cervical cancer, and fertility preservation. His recent works include exploring predictive markers and synergistic agents for drug repositioning of statins in ovarian cancer, and contributing to the Japan Society of Clinical Oncology Clinical Practice Guidelines for fertility preservation. Aoki's research on the clonality of STICs in RRSO samples and the impact of cervical conization on preterm delivery risk further exemplifies his extensive expertise and dedication to improving patient outcomes in gynecologic oncology.

Aliases

D Aoki, D. Aoki, Daisuke Aoki

Publication and Citation Metrics

Metric	Value
Total Citation Count	11,438
h-index	51
Total Paper Count	644

Publications:

Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer

DOI: 10.3390/ph15020124

Year: 2022

Keio Uterus Transplantation Research: From Basic Research toward Future Clinical Application

DOI: 10.2302/kjm.2021-0008-ir

Year: 2022

Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2

DOI: 10.1007/s10147-021-02076-7

Year: 2022

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples

DOI: 10.3802/jgo.2022.33.e50

Year: 2022

Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1

DOI: 10.1007/s10147-021-02081-w

Year: 2022

Aurora kinase blockade drives de novo addiction of cervical squamous cell carcinoma to druggable EGFR signalling

DOI: 10.1038/s41388-022-02256-3

Year: 2022

Status of cervical cancer screening among adolescents and young adults (AYA) in Japan

DOI: 10.1007/s10147-021-02100-w

Year: 2022

Adenocarcinoma in situ or early-stage cervical cancer is a risk factor for preterm delivery after cervical conization: a multicenter observational study.

DOI: 10.1080/14767058.2022.2056835

Year: 2022

Considerations in performing hysterectomy secondary to uterus transplantation.

DOI: 10.1111/aogs.14368

Year: 2022

Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study.

DOI: 10.3802/jgo.2022.33.e3

Year: 2021

What is the future of gynecological testing?

How Do Gynecologists Stay Innovative?

How does ITP affect menstrual health?

What Makes a Research Publication Credible?

What is a Miscarriage?

Are There Specific Laws for Reproductive Technologies?

How Can Healthcare Providers Address Vulnerability?

How Can We Improve Equitable Access?

How Can Lactation Issues Be Addressed?

What is Calcium Gluconate?

Partnered Content Networks

Relevant Topics